[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 23.23.50.247. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
June 1973

Naltrexone, an Antagonist for the Treatment of Heroin DependenceEffects in Man

Author Affiliations

Lexington, Ky
From the National Institute of Mental Health, Addiction Research Center, Lexington, Ky. Dr. Mansky is now with Lindeman Mental Health Center, Boston.

Arch Gen Psychiatry. 1973;28(6):784-791. doi:10.1001/archpsyc.1973.01750360022003
Abstract

Naltrexone (EN-1639A) is approximately 17 times more potent than nalorphine as an antagonist in man. It is virtually devoid of agonistic activity, including the ability to induce nalorphine-like dysphoric effects. Its duration of action is longer than that of naloxone, but shorter than that of cyclazocine. It is effective orally. When administered in a dose level of 50 mg/day, it produces a degree of blockade of the effects of morphine and heroin that is comparable to that obtained with 4 mg of cyclazocine per day orally. Naltrexone, thus, appears to be a relatively pure potent narcotic antagonist which is effective orally and which may have utility in the treatment of heroin and narcotic dependence.

×